Preclinical assessment of viral vectored and protein vaccines targeting the Duffy-binding protein region II of Plasmodium vivaxArticle English OPEN
Simone C de Cassan; A. Rushdi Shakri; David eLlewellyn; Sean C Elias; Jee Sun Cho; Jee Sun Cho; Anna L Goodman; Jing eJin; Alexander D Douglas; Rossarin eSuwanarusk; Rossarin eSuwanarusk; François H Nosten; Laurent eRénia; Laurent eRénia; Bruce eRussell; Chetan E Chitnis; Chetan E Chitnis; Simon J Draper; (2015)
- Publisher: Frontiers Media S.A.
- Journal: Frontiers in Immunology (issn: 1664-3224)
- Related identifiers: ,
Subject: RC581-607 | Plasmodium vivax | Vaccines | MVA | Malaria | Immunologic diseases. Allergy | Adenoviruses, Human
mesheuropmc: parasitic diseases
Malaria vaccine development has largely focused on Plasmodium falciparum; however a reawakening to the importance of P. vivax has spurred efforts to develop vaccines against this difficult to treat and at times severe form of relapsing malaria, which constitutes a signi... View more